TY -的A2 Kershaw David b . AU - Vanerio Gabriel AU -加西亚,克里斯蒂娜AU -冈萨雷斯,Carlota盟——Ferreiro Alejandro PY - 2014 DA - 2014/05/26 TI -死亡患者肾脏替代治疗和永久心脏起搏器SP - 284172六世- 2014 AB -结束阶段肾脏疾病是一个相对频繁的与高死亡率疾病因心脏原因。永久起搏器(PM)植入率也很常见;因此两者的结合条件并不罕见。我们假设慢性肾脏疾病患者和一个点会明显高于死亡率与结束阶段肾病患者相比无点。我们的目标是分析患者的死亡率与点肾脏替代治疗。2778患者肾脏替代治疗(RRT)和110点植入在研究期间。协变量的减少干扰,propensity-matched得分。52 PM患者和208 non-PM匹配患者比较。41%的点被植入在进入在RRT RRT程序和59%。下午组的死亡率更高。 Cardiovascular disease and infections were the most frequent causes of death. Propensity analysis showed no differences in long-term mortality between groups. We concluded that in patients on RRT and PM mortality rates are higher. Survival curves did not differ from a RRT propensity-matched group. We concluded that the presence of a PM is not an independent mortality risk factor in RRT patients. SN - 2090-214X UR - https://doi.org/10.1155/2014/284172 DO - 10.1155/2014/284172 JF - International Journal of Nephrology PB - Hindawi Publishing Corporation KW - ER -